Ask for information without obligation

    In accordance with the provisions of the General Data Protection Regulation (REGULATION (EU) 2016/679), the following information about the processing of personal data is disclosed to you.Responsible: Institut Català de la Retina, S.L., Institut Català de Cirurgia refractiva, S.L. (from now on ICR) Representative of Data Protection Contact: C/Pau Alcover nº 67 08017 Barcelona Aim: The purpose of the treatment is to provide you with the information you requested and other ophthalmology information of your interest. Legitimization: The legal basis for the present treatment is the request made by you. Recipients: The recipients of the information are the departments and delegations in which ICR is organized, in part or in its entirety. It will not be communicated to third parties. Rights: At any time, you can exercise your rights of access, rectification, deletion, opposition, limitation of treatment and / or portability of data by writing to the RPD Representative of Data Protection at the address provided in contact. You can also revoke consents to other treatments. You can also request more information from the RPD about the treatments performed. In the event that you consider that your rights have been violated, you can submit a claim to the competent Data Protection Control Authority. Preservation: The collected data will be kept during the time required for the requested management, for at most 30 days.

    Photo in the contact form: VIU 20/20

    Pictograma amb un ull i un símbol de recuperació

    Painless, non-invasive method to treat all kinds of dry eye disease

    Benefits are fast noticeable and remain in the long term

    pictograma sobre la durada aproximada de la cirurgia de cataractes )20 minuts)

    It is applied in a total of 4 weekly 20-minute sessions

    What is it?

    Quantum Molecular Resonance or QMR is an innovative technology that is starting to be used as a non-invasive treatment for dry eye disease.

    QMR uses quantic energy upon molecular links without damaging cells, preserving and regenerating tissue. The device using this technology sends an alternating, low power, high frequency electric signal in order to stimulate metabolism and natural regeneration of cells and tissue that are not correctly working, such as lacrimal or Meibomian glands in the case of dry eye disease.

    Its safety and effectiveness are supported by multiple research studies.

    Who is it recommended for?

    La prova IDRA es fa abans de prescriure el tractament QMR per a l'ull sec

    QMR technology has other uses in medicine and physical therapy. In ophthalmology it is currently used to treat all kinds of dry eye disease. This means that both aqueous-deficient, evaporative and mixed forms of dry eye disease can be treated with this therapy. All patients suffering from this syndrome could benefit from it.

    However, in order to prescribe the treatment, the medical team at the Dry Eye Unit must first carry out an examination of the patient in question, which will include lacrimal function tests, such as the IDRA® device.

    It is only not recommended for women who are pregnant or planning to become pregnant in the near future, babies and young children, people with implantable devices (such as pacemakers or hearing aids), oncology patients undergoing treatment, and patients who have undergone eye surgery within the past month.

    How is it performed?

    Quantum Molecular Resonance for the treatment of dry eye disease is applied using a device called Rexon Eye®, specifically designed for ophthalmological use and CE-certified for the treatment of ocular surface disorders.

    The treatment consists of four weekly sessions, each lasting 20 minutes.

    During each session, a mask with integrated contact electrodes is placed over the patient’s closed eyes. Through these electrodes, currents are delivered that create a pleasant warming sensation in the eyelid area. It is very unlikely, but if the patient were to feel any discomfort or pain, they could press a button to stop the treatment immediately and discuss it with the professional.

    After the procedure

    After the application of QMR, it is necessary to rest the eyes for about 15 minutes. The patient may experience temporary blurred vision, caused by the slight pressure of the mask on the eyes. Once this symptom has disappeared (within 15–30 minutes at most), they can go home on their own, even driving.

    Few (and mild) complications or side effects of the treatment have been reported, which may include periocular discomfort, inflammation, erythema, or slight skin discoloration. In any case, these effects subside shortly after the application of QMR.

    Benefits

    This treatment offers many advantages for dry eye patients, first and foremost because it provides an effective solution to a syndrome that, in some cases, previously had no definitive treatment.

    Secondly, it is an outpatient, painless, and non-invasive procedure (even comfortable for the patient) that also surpasses the effectiveness of some previous treatment options.

    Finally, the benefits can be noticed from 4 to 6 weeks after completing all QMR sessions and may last for up to about 2 years, during which patients can enjoy relief from the symptoms of dry eye disease.

    Medical content revised by - Last revision 19/05/2025

    Do you have any questions?

    Contact us or request an appointment with our medical team.